Novel Biotech-Based Field or Lab Assay for Detection of Fluoride
|
By LabMedica International staff writers Posted on 26 Dec 2019 |

Image: The test tube on the left shows a real positive result from water sampled in Costa Rica. The middle tube is a negative control. The tube on the right is a positive control (Photo courtesy of Dr. Julius B. Lucks, Northwestern University)
A simple, yet sophisticated biotech-based assay for the detection of fluoride levels was successfully tested in the laboratory and in the field.
Around one-third of the human population drinks water from groundwater resources. Of this, about 10%, approximately three hundred million people, obtain water from groundwater resources that are heavily contaminated with arsenic or fluoride. When consumed in high amounts over long periods of time, fluoride can cause skeletal fluorosis, a painful condition that hardens bones and joints.
Current laboratory methods to measure fluoride levels in groundwater are expensive and time consuming and may not be available in developing countries. Investigators at Northwestern University (Evanston, IL, USA) suggest replacing this methodology with a rapid, easy-to-use, inexpensive biotech-based assay.
This assay comprises a biosensor consisting of a cell-free system containing a DNA template that encodes a fluoride-responsive riboswitch, which regulates genes that produce a fluorescent or colorimetric output. A riboswitch is a regulatory segment of a messenger RNA molecule that binds a small molecule, resulting in a change in production of the proteins encoded by the mRNA. Thus, an mRNA that contains a riboswitch is directly involved in regulating its own activity, in response to the concentrations of its effector molecule. In the current assay system, the presence of fluoride causes the RNA to produce a protein enzyme that makes a yellow pigment that is readily visible to the naked eye.
Senior author Dr. Julius Lucks, associate professor of chemical and biological engineering at Northwestern University, said, "RNA folds into a little pocket and waits for a fluoride ion. The ion can fit perfectly into that pocket. If the ion shows up, then RNA expresses a gene that turns the water yellow. If the ion does not show up, then RNA changes shape and stops the process. It is literally a switch."
Reagents for individualized tests may be lyophilized for long-term storage. Following reconstitution with 20 microliters of liquid sample and incubation at room temperature for two hours, the test could detect fluoride at levels above two parts per million, the [U.S.] Environmental Protection Agency’s most stringent regulatory standard, in both laboratory and field conditions.
The prototype assay was successfully tested in Costa Rica, where the Irazu volcano causes heavy contamination of the groundwater with fluoride.
"In the United States, we hear about fluoride all the time because it is in toothpaste and the municipal water supply," said Dr. Lucks. "It makes calcium fluoride, which is very hard, so it strengthens our tooth enamel. But above a certain level, fluoride also hardens joints. This mostly is not an issue in the United States. But it can be a debilitating problem in other countries if not identified and addressed. Every test on these field samples worked. It is exciting that it works in the lab, but it is much more important to know that it works in the field. We want it to be an easy, practical solution for people who have the greatest need. Our goal is to empower individuals to monitor the presence of fluoride in their own water."
The fluoride detection test was described in the December 13, 2019, online edition of the journal ACS Synthetic Biology.
Related Links:
Northwestern University
Around one-third of the human population drinks water from groundwater resources. Of this, about 10%, approximately three hundred million people, obtain water from groundwater resources that are heavily contaminated with arsenic or fluoride. When consumed in high amounts over long periods of time, fluoride can cause skeletal fluorosis, a painful condition that hardens bones and joints.
Current laboratory methods to measure fluoride levels in groundwater are expensive and time consuming and may not be available in developing countries. Investigators at Northwestern University (Evanston, IL, USA) suggest replacing this methodology with a rapid, easy-to-use, inexpensive biotech-based assay.
This assay comprises a biosensor consisting of a cell-free system containing a DNA template that encodes a fluoride-responsive riboswitch, which regulates genes that produce a fluorescent or colorimetric output. A riboswitch is a regulatory segment of a messenger RNA molecule that binds a small molecule, resulting in a change in production of the proteins encoded by the mRNA. Thus, an mRNA that contains a riboswitch is directly involved in regulating its own activity, in response to the concentrations of its effector molecule. In the current assay system, the presence of fluoride causes the RNA to produce a protein enzyme that makes a yellow pigment that is readily visible to the naked eye.
Senior author Dr. Julius Lucks, associate professor of chemical and biological engineering at Northwestern University, said, "RNA folds into a little pocket and waits for a fluoride ion. The ion can fit perfectly into that pocket. If the ion shows up, then RNA expresses a gene that turns the water yellow. If the ion does not show up, then RNA changes shape and stops the process. It is literally a switch."
Reagents for individualized tests may be lyophilized for long-term storage. Following reconstitution with 20 microliters of liquid sample and incubation at room temperature for two hours, the test could detect fluoride at levels above two parts per million, the [U.S.] Environmental Protection Agency’s most stringent regulatory standard, in both laboratory and field conditions.
The prototype assay was successfully tested in Costa Rica, where the Irazu volcano causes heavy contamination of the groundwater with fluoride.
"In the United States, we hear about fluoride all the time because it is in toothpaste and the municipal water supply," said Dr. Lucks. "It makes calcium fluoride, which is very hard, so it strengthens our tooth enamel. But above a certain level, fluoride also hardens joints. This mostly is not an issue in the United States. But it can be a debilitating problem in other countries if not identified and addressed. Every test on these field samples worked. It is exciting that it works in the lab, but it is much more important to know that it works in the field. We want it to be an easy, practical solution for people who have the greatest need. Our goal is to empower individuals to monitor the presence of fluoride in their own water."
The fluoride detection test was described in the December 13, 2019, online edition of the journal ACS Synthetic Biology.
Related Links:
Northwestern University
Latest Technology News
- AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
- Agentic AI Platform Supports Genomic Decision-Making in Oncology
- Algorithm Panel Aids Liver Fibrosis Assessment and Liver Cancer Surveillance
- Mailed Screening Kits Help Reduce Colorectal Cancer Screening Gaps
- AI-Enabled Assistant Unifies Molecular Workflow Planning and Support
- AI Tool Automates Validation of Laboratory Software Configuration Changes
- Point-of-Care Testing Enhances Health Literacy and Self-Management in Chronic Disease
- Fully Automated Sample-to-Insight Workflow Advances Latent TB Testing
- Tumor-on-a-Chip Platform Models Pancreatic Cancer Treatment Response
- New Platform Captures Extracellular Vesicles for Early Cancer Detection
- Microfluidic Single-Cell Assay Predicts Breast Cancer Risk
- AI Tool Predicts Non-Response to Targeted Therapy in Colorectal Cancer
- Integrated System Streamlines Pre-Analytical Workflow for Molecular Testing
- Noninvasive Sputum Test Detects Early Lung Cancer
- New AI Tool Enables Rapid Treatment Selection in Pediatric Leukemia
- Rapid Biosensor Detects Drug Sensitivity in Breast Tumors
Channels
Clinical Chemistry
view channel
Blood Protein Signature Diagnoses Pediatric IBD and Distinguishes Subtypes
Confirming pediatric inflammatory bowel disease (IBD) often requires imaging, endoscopy, and histopathology, prolonging time to diagnosis. Reliable, noninvasive blood tests remain an unmet need in routine... Read more
Blood Test Detects More High-Risk Prostate Cancers Than PSA
Prostate cancer is one of the most common malignancies in men, and screening often struggles to distinguish indolent tumors from clinically significant disease. Prostate-specific antigen (PSA) testing... Read moreHematology
view channel
Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows
Sysmex America (Chicago, IL, USA) has introduced the next generation XR-Series, centered on the XR-10 Automated Hematology Module for high-complexity laboratories. The platform builds on the widely used... Read more
Blood Eosinophil Count May Predict Cancer Immunotherapy Response and Toxicity
Immune checkpoint inhibitors have improved outcomes across many cancers, yet only a subset of patients derive durable benefit and biomarkers to guide treatment remain limited. Eosinophils, best known for... Read moreImmunology
view channel
Lung Immune Profiling Reveals Distinct Severe Pneumonia Subtypes
Severe pneumonia often progresses to respiratory failure requiring intensive care and mechanical ventilation. Despite similar clinical presentations, outcomes vary widely, complicating decisions on an... Read more
Lab-on-a-Chip Approach Advances Immune–Cancer Cell Interaction Analysis
Conventional cytotoxicity assays often average responses across thousands of cells, obscuring how individual immune cells engage and kill tumor cells. For immunotherapy evaluation, the precise sequence... Read moreMicrobiology
view channel
Study Reveals Widespread Community Spread of Drug-Resistant Klebsiella
Multidrug-resistant Klebsiella pneumoniae is an escalating community health concern, driving recurrent urinary tract infections in older adults and complicating first-line antibiotic therapy.... Read more
Stronger Laboratory Services Support Timely Melioidosis Diagnosis Amid Global Spread
Melioidosis, a potentially fatal infection caused by Burkholderia pseudomallei, remains difficult to recognize because its symptoms can mimic tuberculosis and other illnesses. The disease is considered... Read more
Extracellular Vesicle Biomarker May Enable Noninvasive Monitoring of H. pylori
Helicobacter pylori infects an estimated 43.9% of the global population, affecting approximately 4.4 billion people worldwide. In many regions, including Africa, Eastern Europe, and Southeast Asia, prevalence... Read more
Rapid Molecular Screening Aims to Accelerate Hospital Infection Control for CPE
Drug-resistant infections remain a critical patient-safety threat in hospitals, with carbapenemase-producing Enterobacterales (CPE) among the most urgent concerns. In England, reports of acquired carbapenemase... Read morePathology
view channel
Uncertainty-Aware AI Tool Improves Digital Pathology for Cancer Subtyping
Reliable histologic subtyping guides therapy selection in oncology, yet diagnostic workflows grow more complex as whole-slide imaging and artificial intelligence (AI) expand. A persistent obstacle to clinical... Read more
Study Highlights Biomarker Testing Delays in Lung Cancer Care
Timely biomarker results are critical to match lung cancer patients with targeted therapies or immunotherapies, yet many clinical pathways still delay testing after biopsy. Ordering responsibility, reimbursement... Read moreTechnology
view channel
AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
Oncology teams must manage growing volumes of genomic data, rapidly evolving clinical trial options, and frequently updated care guidelines, all within tight clinic schedules. Translating complex tumor... Read more
Agentic AI Platform Supports Genomic Decision-Making in Oncology
Oncology care teams increasingly face the challenge of managing complex molecular diagnostics, evolving treatment options, and extensive electronic health record documentation. Translating multimodal data... Read moreIndustry
view channel
Agreement Supports pTau217-Based Alzheimer’s Blood Test Development
As disease-modifying therapies for Alzheimer’s disease expand, accessible diagnostics are increasingly needed to identify patients earlier. Current confirmatory methods, including PET imaging and cerebrospinal... Read more




.jpg)



